CLASS II ONGOING Device recall · Reported 15 Jun 2022 · FDA Enforcement Report

NeuMoDx Flu A-B/RSV/Sars-CoV-2 Vantage Test Strip recalled

NeuMoDx Molecular is recalling NeuMoDx Flu A-B/RSV/Sars-CoV-2 Vantage Test Strip, distributed in 10 states. The recall was initiated on 13 May 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI-DI (GTIN): 10814278020830 Cartridge lot numbers 111915 - 117508
Quantity recalled459 kits US; 1626 kits OUS

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1251-2022
FDA event ID
90275
Recalling firm
NeuMoDx Molecular, Ann Arbor, MI
Classification
Class II
Status
Ongoing
Recall initiated
13 May 2022
FDA classified
8 Jun 2022
Reported
15 Jun 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Lead & Heavy Metals

Timeline

13 May 2022Recall initiated by company
8 Jun 2022Classified by FDA+26 days
15 Jun 2022Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

There is a potential for reduced analytical sensitivity for samples in the 1x - 3x LOD range for Flu A, RSV, and SARS-CoV-2 targets. This may lead to false negative results, allowing ongoing transmission to others and delaying appropriate treatment.

Lead and other heavy metals accumulate in the body. Children are most at risk; even low levels can affect development.

Product as listed by the FDA

NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test Strip, Model No. 300900

Where it was distributed

Domestic distribution to FL, NY, MD, PA, VA, MI, TN, NM. Foreign distribution to AT, AU, BE, CH, DE, FI, FR, GB, GR, HK, ID, IT, LT, NL, SA, SE, and SI.

DelawareFloridaIdahoMarylandMichiganNew MexicoNew YorkPennsylvaniaTennesseeVirginia

Questions about this recall

Is NeuMoDx Flu A-B/RSV/Sars-CoV-2 Vantage Test Strip recalled?

Yes. NeuMoDx Molecular recalled NeuMoDx Flu A-B/RSV/Sars-CoV-2 Vantage Test Strip on 13 May 2022. The recall is Class II and its status is Ongoing. Recall number Z-1251-2022.

Why was it recalled?

There is a potential for reduced analytical sensitivity for samples in the 1x - 3x LOD range for Flu A, RSV, and SARS-CoV-2 targets. This may lead to false negative results, allowing ongoing transmission to others and delaying appropriate treatment.

Which lots are affected?

UDI-DI (GTIN): 10814278020830 Cartridge lot numbers 111915 - 117508

Where was it sold?

Domestic distribution to FL, NY, MD, PA, VA, MI, TN, NM. Foreign distribution to AT, AU, BE, CH, DE, FI, FR, GB, GR, HK, ID, IT, LT, NL, SA, SE, and SI.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from NeuMoDx Molecular

All 6

Other Insulin Pumps & Glucose Monitors recalls

All 459